Cresco Labs, one of the largest vertically integrated multistate cannabis operators in the United States, announced that it has received approval from the Arizona Department of Health Services (ADHS) to serve adult-use customers at its Sunnyside dispensary in Phoenix.
“As a company, our strategy is to invest our resources in only the most strategic markets with appropriate regulations and strong consumer demand. For the last 10 years, not only has Arizona administered a responsible medical cannabis program, but has also garnered strong participation with more than 300,000 active patients,” said Charlie Bachtell, CEO and Co-founder of Cresco Labs.
Cresco Labs’ Sunnyside dispensary is located at 2620 West Encanto Boulevard in Phoenix and is co-located with a state-of-the-art cultivation and processing facility. Cresco Labs’ wholesale strategy is also supported by another cultivation facility in Vicksburg, Arizona.
David Gacom, Regional President, West Region, added, “We are excited to welcome adult-use customers to Sunnyside Phoenix and look forward to serving them with the same enthusiasm and expertise as our Arizona medical patients. With our experience operating in states transitioning to adult-use sales, Cresco Labs has been looking forward to this historic new chapter in Arizona and we are committed to providing a seamless transition for new and existing customers alike.”
On January 22nd, Arizona became the 12th state to begin serving recreational cannabis customers, after a majority of residents voted in favor of Proposition 207 last November.
Photo: Business Wire